Details for Patent: 9,066,869
✉ Email this page to a colleague
Summary for Patent: 9,066,869
Title: | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations |
Abstract: | The invention is directed to oral modified/controlled release drug formulations which provide a rapid initial onset of effect and a prolonged duration of effect. Preferably, the peak concentration is lower than that provided by the reference standard for immediate release formulations of the drug, and the duration of effect falls rapidly at the end of the dosing interval. |
Inventor(s): | Krishnamurthy; Thinnayam N. (Scarborough, CA), Darke; Andrew (Newmarket, CA) |
Assignee: | Purdue Pharma (Pickering, Ontario, CA) |
Application Number: | 14/049,677 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,066,869 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Dosage form; Use; |
Drugs Protected by US Patent 9,066,869
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,066,869
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 268595 | ⤷ Try a Trial | |||
Australia | 2122700 | ⤷ Try a Trial | |||
Canada | 2355854 | ⤷ Try a Trial | |||
Germany | 69917937 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |